Journal article
Prevalence and Causes of Fatal Outcome in Catheter Ablation of Atrial Fibrillation
R Cappato, H Calkins, SA Chen, W Davies, Y Iesaka, J Kalman, YH Kim, G Klein, A Natale, D Packer, A Skanes
Journal of the American College of Cardiology | ELSEVIER SCIENCE INC | Published : 2009
Abstract
Objectives: The purpose of this study was to provide a systematic multicenter survey on the incidence and causes of death occurring in the setting of or as a consequence of catheter ablation (CA) of atrial fibrillation (AF). Background: CA of AF is considered to be generally safe. However, serious complications, including death, have been reported. Methods: Using a retrospective case series, data relevant to the incidence and cause of intra- and post-procedural death occurring in patients undergoing CA of AF between 1995 and 2006 were collected from 162 of 546 identified centers worldwide. Results: Thirty-two deaths (0.98 per 1,000 patients) were reported during 45,115 procedures in 32,569 p..
View full abstractGrants
Funding Acknowledgements
Dr. Cappato is a consultant and speaker for Biosense Webster and St. Jude Medical, a consultant for Bard, on the Advisory Board for St. Jude Medical, and has received research grants from Biosense Webster, St. Jude Medical, and Bard. Dr. Calkins is a consultant for Ablation Frontiers, Biosense Webster, and Boston Scientific, and has received stock options from Ablation Frontiers, fellowship and research support from Biosense Webster, and lecture support from St. Jude Medical. Dr. Davies is a consultant for Cryocath and Cyberheart. Dr. Kalman has received research grants and fellowship support from St. Jude Medical, Biosense Webster, and Medtronic Inc. Dr. Natale is a speaker for St. Jude Medical and Biosense Webster, and is on the Advisory Board of Biosense Webster, Stereotaxis, and St. Jude Medical. Dr. Packer is a speaker for Biosense Webster, Medtronic, and St. Jude Medical, a consultant for Biosense Webster and Boston Scientific, has received research contracts from Biosense Webster, and is on the Advisory Board of Siemens Medical. Dr. Skanes is on the Physician Advisory Board of and a speaker for Biosense Webster, and has received research grants from Biosense Webster.